Growth Metrics

Eli Lilly (LLY) Current Taxes (2016 - 2025)

Eli Lilly filings provide 17 years of Current Taxes readings, the most recent being $9.4 billion for Q3 2025.

  • On a quarterly basis, Current Taxes changed N/A to $9.4 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $9.4 billion, a N/A change, with the full-year FY2024 number at $1.1 billion, changed N/A from a year prior.
  • Current Taxes hit $9.4 billion in Q3 2025 for Eli Lilly, up from $7.0 billion in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $9.4 billion in Q3 2025 to a low of $126.6 million in Q2 2022.
  • Median Current Taxes over the past 5 years was $791.6 million (2021), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Current Taxes: crashed 82.66% in 2021 and later soared 874.57% in 2023.
  • Eli Lilly's Current Taxes stood at $126.9 million in 2021, then skyrocketed by 274.39% to $475.1 million in 2022, then soared by 316.23% to $2.0 billion in 2023, then tumbled by 43.54% to $1.1 billion in 2024, then surged by 745.97% to $9.4 billion in 2025.
  • The last three reported values for Current Taxes were $9.4 billion (Q3 2025), $7.0 billion (Q2 2025), and $6.2 billion (Q1 2025) per Business Quant data.